Transparency, or the practice of disclosing clinical trial data, is highly important in clinical research. What happens when companies decide to not publish all of their clinical trial results, and fall out of compliance with the FDAA? FDA...
What are the four branches of patient centricity, and how can they apply to your company? In this episode, Darshan Kulkarni explains how companies can foster patient centricity through privacy, transparency, innovation and access. Plus, how the FDA...
Often, clinical trial results do not end up being disclosed. How can companies address this lack of transparency in clinical research? Darshan Kulkarni investigates the four ways in which health care companies can improve data transparency while...
Patient centricity has become a major focal point for companies in 2019. What are four ways life science companies can incorporate patient centricity? Join Darshan Kulkarni as he discusses how health care companies can implement more patient-centric...
As pharmacy continues to grow, what changes can we expect to see in 2020? How will privacy laws and telepharmacy affect life science companies? And how will the FDA respond to cannabis supportive laws? We investigate these questions and more with...
The consequences of committing pharmacy fraud are often costly. How can pharmaceutical companies navigate various state and federal laws and remain compliant? Former pharmacist Darshan Kulkarni discusses the six major trends in 2019 surrounding...